cilostazol has been researched along with Testicular Diseases in 1 studies
Testicular Diseases: Pathological processes of the TESTIS.
| Excerpt | Relevance | Reference |
|---|---|---|
| "Cilostazol (CLZ) is a selective phosphodiesterase (PDE) 3A inhibitor used for treatment of intermittent claudication." | 1.62 | Dose dependent effect of cilostazol in induced testicular ischemia reperfusion via modulation of HIF/VEGF and cAMP/SIRT1 pathways. ( Ahmed Ibrahim, R; Refaie, MMM; Shehata, S, 2021) |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 0 (0.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 1 (100.00) | 2.80 |
| Authors | Studies |
|---|---|
| Refaie, MMM | 1 |
| Ahmed Ibrahim, R | 1 |
| Shehata, S | 1 |
| Trial | Phase | Enrollment | Study Type | Start Date | Status | ||
|---|---|---|---|---|---|---|---|
| Evaluation of the Effect of Cilostazol on the Clinical Outcomes of Rheumatoid Arthritis Patients[NCT05671497] | Phase 2/Phase 3 | 70 participants (Anticipated) | Interventional | 2022-11-01 | Recruiting | ||
| [information is prepared from clinicaltrials.gov, extracted Sep-2024] | |||||||
1 other study available for cilostazol and Testicular Diseases
| Article | Year |
|---|---|
Dose dependent effect of cilostazol in induced testicular ischemia reperfusion via modulation of HIF/VEGF and cAMP/SIRT1 pathways.
Topics: Animals; Blotting, Western; Cilostazol; Cyclic AMP; Dose-Response Relationship, Drug; Interleukin-1b | 2021 |